Phio Pharmaceuticals Corp (PHIO): RXi Pharmaceuticals to Present at the 3r...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	5248
Boards Moderated	0
Alias Born	10/16/2012

The Other Guy

Re: None

Tuesday, 05/23/2017 1:24:59 PM

Tuesday, May 23, 2017 1:24:59 PM

RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum

Source: PR Newswire (US)
MARLBOROUGH, Mass., May 23, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that Dr. Alexey Eliseev, RXi's Chief Business Officer, will present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum. This forum will bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. The meeting will take place on June 2, 2017 at the Hyatt Chicago Magnificent Mile Hotel in Illinois.

June 2, 2017 at 12:10pm Central, Track B
Alexey Eliseev, PhD, Chief Business Officer, RXi Pharmaceuticals
Targeting Immune Checkpoints in Adoptive Cell Transfer Using Self-Delivering RNAi (sd-rxRNA®) Technology